Clinical Trials Logo

Clinical Trial Summary

To evaluate the efficacy and safety of CertiroBell® tablet plus tacrolimus

Clinical Trial Description

This study is multi-center, single arm, open-label, phase 4 study to evaluate the efficacy and safety of CertiroBell® tablet plus tacrolimus in primary living donor liver transplant recipients. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04867720
Study type Interventional
Source Chong Kun Dang Pharmaceutical
Contact Kyung-Suk Suh, M.D., Ph.D.
Phone 82-2-2072-7200
Email [email protected]
Status Recruiting
Phase Phase 4
Start date March 16, 2021
Completion date February 22, 2023

See also
  Status Clinical Trial Phase
Completed NCT02798861 - Controlled Attenuation Parameter (CAP) in Liver Allografts
Active, not recruiting NCT03527238 - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine Phase 2
Completed NCT01696331 - Text Messaging for Adherence in Adolescent Liver Transplant Recipients N/A
Completed NCT01598987 - Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients. Phase 3
Recruiting NCT04836923 - LIFT Intervention in Liver Transplant Candidates N/A
Not yet recruiting NCT03666689 - Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation
Terminated NCT01230502 - Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation N/A
Recruiting NCT04089969 - Cardiac Risk Assessment Using Standard of Care Versus CTA and Heart Flow FFRct N/A
Completed NCT00171509 - Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients Phase 4
Completed NCT02057484 - A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
Recruiting NCT03577431 - Liver Transplantation With Tregs at MGH Phase 1/Phase 2
Not yet recruiting NCT04265157 - Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant
Recruiting NCT02863250 - Australian and New Zealand Massive Transfusion Registry
Completed NCT00698399 - Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients N/A
Completed NCT00320606 - Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients Phase 1
Recruiting NCT04471441 - Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. Phase 4
Terminated NCT02743793 - A Cohort Study of Operationally Tolerant Allograft Recipients
Recruiting NCT03515330 - A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients N/A
Not yet recruiting NCT04721288 - REmote moBile Outpatient mOnitoring in Transplant 2.0 N/A
Completed NCT02776553 - A Physical Activity Program in End-state Liver Disease N/A